Aurora Cannabis Strengthens Leadership Group Adding Chief Solution Officer and Chief Integration Officer – New Cannabis Ventures

[ad_1]

Appoints Dr. Shane Morris CPO and André Jérôme CIO

EDMONTON, Nov. 20, 2019 /PRNewswire/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE │ TSX: ACB), the Canadian organization defining the future of cannabis worldwide, is pleased to announce that powerful straight away, Dr. Shane Morris, formerly Senior Vice President of Solution Improvement and Regulatory Affairs, has been promoted to Chief Solution Officer, and André Jérôme, formerly Senior Vice President of Company Integrations, has been promoted to Chief Integration Officer.

Aurora is committed to sustaining its worldwide leadership position in the cannabis business and we have constructed a sturdy group that will drive the future development and strategic improvement of the small business.

Terry Booth, CEO

Shane has played a essential part in overseeing Aurora’s item improvement and regulatory initiatives which have resulted in the profitable launch of quite a few novel item types and the profitable management of our quite a few web site licences. As we enter the subsequent phase of customer legalization in Canada and worldwide expansion, Shane will play a essential part in making certain we continue to have the appropriate mix of merchandise in all markets that will resonate with each our individuals and shoppers.

Mr. Booth added, “With diverse small business integration expertise, André has played a essential part in the profitable integration of our worldwide assets and subsequently making certain we continue to drive sturdy worth from these transactions for our investors. André’s contributions have permitted us to strategically assemble a portfolio of higher-high-quality assets that with each other are uniquely positioned to continue to lead the worldwide cannabis business.”

Chief Solution Officer

Dr. Morris joined Aurora in January 2018 to lead the Company’s item improvement and regulatory affairs initiatives. Committed to science-primarily based, customer-focused innovation, Dr. Morris has led the improvement, regulatory oversight and industry introduction for various of the Company’s revolutionary cannabis merchandise, like Aurora’s Oral Mist, Oral Dissolve Strips, and Aurora Cloud, the initial-ever vape-prepared oil cartridge to be introduced beneath Wellness Canada regulations. In his new part, Dr. Morris will be accountable for the Company’s item improvement for the Canadian and international markets. Dr. Morris holds a Ph.D. in plant science and policy from the National University of Ireland (NUI), Galway and a B.Sc. in biology and mathematics from NUI, Maynooth.

Chief Integration Officer

Mr. Jérôme joined Aurora in February 2018 by means of the acquisition of H2 Biopharma which now operates as the Company’s Aurora Eau facility in Lachute, Quebec. Initially accountable for the integration of Aurora’s acquisitions as properly as the identification of synergies across current subsidiaries and joint venture partners, Mr. Jérôme’s part has expanded more than the final 18 months to include things like Worldwide Safety, Wellness, Security &amp Atmosphere, and oversight for a quantity of subsidiaries. As Chief Integration Officer, André will oversee all existing and future integrations with a concentrate on worth generation to assistance the Company’s expansion tactic. Mr. Jérôme has led the profitable integration of quite a few of Aurora’s biggest small business assets like CanniMed Therapeutics, MedReleaf, Whistler Cannabis and Anandia Laboratories.

About Aurora

Headquartered in Edmonton, Alberta, Canada with funded capacity in excess of 625,000 kg per annum and sales and operations in 25 nations across 5 continents, Aurora is a single of the world’s biggest and major cannabis businesses. Aurora is vertically integrated and horizontally diversified across each and every crucial segment of the worth chain, from facility engineering and design and style to cannabis breeding and genetics analysis, cannabis and hemp production, derivatives, higher worth-add item improvement, dwelling cultivation, wholesale and retail distribution.

Extremely differentiated from its peers, Aurora has established a uniquely sophisticated, constant and effective production tactic, primarily based on goal-constructed facilities that integrate major-edge technologies across all processes, defined by substantial automation and customization, resulting in the huge scale production of higher-high-quality constant item. Developed to be replicable and scalable globally, our production facilities are developed to create cannabis at considerable scale, with higher high-quality, business-major yields, and low-per gram production charges. Every of Aurora’s facilities is constructed to meet European Union Very good Manufacturing Practices (“EU GMP”) requirements. Certification has been granted to Aurora’s initial production facility in Mountain View County, the MedReleaf Markham facility, and its wholly owned European health-related cannabis distributor Aurora Deutschland. All Aurora facilities are developed and constructed to the EU GMP common.

In addition to the Company’s speedy organic development and sturdy execution on strategic M&ampA, which to date incorporates 17 wholly owned subsidiary businesses – MedReleaf, CanvasRX, Peloton Pharmaceutical, Aurora Deutschland, H2 Biopharma, BC Northern Lights, Larssen Greenhouses, CanniMed Therapeutics, Anandia, HotHouse Consulting, MED Colombia, Agropro, Borela, ICC Labs, Whistler, Chemi Pharmaceutical, and Hempco – Aurora is distinguished by its reputation as a companion and employer of option in the worldwide cannabis sector, obtaining invested in and established strategic partnerships with a variety of major innovators, like: Radient Technologies Inc. (TSXV: RTI), Cann Group Ltd. (ASX: CAN), Micron Waste Technologies Inc. (CSE: MWM), Choom Holdings Inc. (CSE: CHOO), CTT Pharmaceuticals (OTCC: CTTH), Alcanna Inc. (TSX: CLIQ), Higher Tide Inc. (CSE: HITI), EnWave Corporation (TSXV: ENW), Capcium Inc. (private), Evio Beauty Group (private), and Wagner Dimas (private).

Aurora’s Typical Shares trade on the TSX and NYSE beneath the symbol “ACB”, and is a constituent of the S&ampP/TSX Composite Index.

For additional data about Aurora, please pay a visit to our investor web page, investor.auroramj.com

Original Press Release

Published by NCV Newswire

NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate higher high-quality content material and data about major cannabis businesses to assist our readers filter out the noise and to remain on top rated of the most vital cannabis small business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter

&#13 &#13
&#13
&#13


[ad_2]

Latest posts